These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3859750)

  • 1. Prevalence of HTLV-III antibody in American blood donors.
    Schorr JB; Berkowitz A; Cumming PD; Katz AJ; Sandler SG
    N Engl J Med; 1985 Aug; 313(6):384-5. PubMed ID: 3859750
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of anti-HTLV-III antibodies in blood donors and risk populations in Zaragoza].
    Callén L; Gutiérrez M; Lasierra P; Larrad L
    Med Clin (Barc); 1986 Jun; 87(2):82. PubMed ID: 3461230
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?
    Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF
    N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevalence of anti-HTLV-III antibodies in volunteer blood donors in Guipuzcoa].
    Cortés A; Francisco C; Larrañaga MJ; Cárdenas JM
    Med Clin (Barc); 1987 Jan; 88(1):38-9. PubMed ID: 3644127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HTLV III testing of blood donors and recipients, Hawaii experience.
    Frohlich J
    Hawaii Med J; 1986 Nov; 45(11):391-2. PubMed ID: 3468095
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus development summaries. The impact of routine HTLV-III antibody testing of blood and plasma donors on public health. National Institutes of Health.
    Conn Med; 1986 Nov; 50(11):745-51. PubMed ID: 3466770
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of anti-HTLV-III testing of volunteer blood donors.
    Grindon AJ
    Beitr Infusionther Klin Ernahr; 1987; 18():1-5. PubMed ID: 3326580
    [No Abstract]   [Full Text] [Related]  

  • 12. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rational microanalysis technic in the detection of antibodies to HTLV-III, CMV and EBV with indirect immunofluorescence].
    Stöcker W; Geusendam G; Schmitz H; Mohr H; Berndt H
    Beitr Infusionther Klin Ernahr; 1986; 15():51-7. PubMed ID: 3019301
    [No Abstract]   [Full Text] [Related]  

  • 14. An analysis of serum samples positive for HTLV-III antibodies.
    Petricciani JC; Seto B; Wells M; Quinnan G; McDougal JS; Bodner AJ
    N Engl J Med; 1985 Jul; 313(1):47-8. PubMed ID: 2582255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence of HTLV-III antibodies in blood donors at the German Red Cross].
    Kubanek B; Koerner K
    Dtsch Med Wochenschr; 1986 Mar; 111(13):516-7. PubMed ID: 3456890
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening blood donors for HTLV-III antibody.
    Mann DA
    JAMA; 1986 Nov; 256(17):2344-5. PubMed ID: 3534328
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for HTLV-III antibodies--a government blunder?
    Bryan CS
    J S C Med Assoc; 1985 Apr; 81(4):242-4. PubMed ID: 2985870
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up testing of blood donors found to be enzyme immunoassay positive/Western blot negative for HTLV-III antibody.
    Cable RG; Kakaiya RM; Roberts SC; Martin CR; Shafer AW; Thaxton J
    JAMA; 1986 Jul; 256(1):40-1. PubMed ID: 3458933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.